Witnessing the stock’s movement on the chart, on September 11, 2020, Atara Biotherapeutics Inc. (NASDAQ: ATRA) set off with pace as it heaved 5.06% to $14.96. During the day, the stock rose to $16.3199 and sunk to $14.52 before settling in for the price of $14.24 at the close. Taking a more long-term approach, ATRA posted a 52-week range of $4.52-$19.36.
Meanwhile, its Annual Earning per share during the time was -0.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -7.70%. This publicly-traded company’s shares outstanding now amounts to $67.98 million, simultaneously with a float of $44.55 million. The organization now has a market capitalization sitting at $1.06 billion. At the time of writing, stock’s 50-day Moving Average stood at $13.44, while the 200-day Moving Average is $12.36.
Atara Biotherapeutics Inc. (ATRA) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. According to the most recent insider trade that took place on Aug 18, this organization’s President and CEO sold 4,807 shares at the rate of 12.09, making the entire transaction reach 58,117 in total value, affecting insider ownership by 260,037. Preceding that transaction, on Aug 18, Company’s Chief Financial Officer sold 1,496 for 12.09, making the whole transaction’s value amount to 18,087. This particular insider is now the holder of 133,530 in total.
Atara Biotherapeutics Inc. (ATRA) Earnings and Revenue Records
As on 6/29/2020, Multinational firm has announced its last quarter scores, in which it reported -$1.14 earnings per share (EPS) for the period topping the consensus outlook (set at -$1.18) by $0.04. This company achieved a return on equity of -92.43. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.11 per share during the current fiscal year.
Atara Biotherapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -7.70% and is forecasted to reach -4.07 in the upcoming year.
Atara Biotherapeutics Inc. (NASDAQ: ATRA) Trading Performance Indicators
Let’s observe the current performance indicators for Atara Biotherapeutics Inc. (ATRA). It’s Quick Ratio in the last reported quarter now stands at 11.30. The Stock has managed to achieve an average true range (ATR) of 1.03.
In the same vein, ATRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.01, a figure that is expected to reach -1.09 in the next quarter, and analysts are predicting that it will be -4.07 at the market close of one year from today.
Technical Analysis of Atara Biotherapeutics Inc. (ATRA)
Going through the that latest performance of [Atara Biotherapeutics Inc., ATRA]. Its last 5-days volume of 1.27 million indicated improvement to the volume of 1.09 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 76.91% While, its Average True Range was 1.10.
Raw Stochastic average of Atara Biotherapeutics Inc. (ATRA) in the period of the previous 100 days is set at 63.06%, which indicates a major fall in contrast to 68.52% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 59.17% that was lower than 95.44% volatility it exhibited in the past 100-days period.